AR229703A1 - Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina - Google Patents

Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina

Info

Publication number
AR229703A1
AR229703A1 AR290461A AR29046182A AR229703A1 AR 229703 A1 AR229703 A1 AR 229703A1 AR 290461 A AR290461 A AR 290461A AR 29046182 A AR29046182 A AR 29046182A AR 229703 A1 AR229703 A1 AR 229703A1
Authority
AR
Argentina
Prior art keywords
heteroariltiazoles
antisecreting
guanidino
agents
procedure
Prior art date
Application number
AR290461A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR229703A1 publication Critical patent/AR229703A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
AR290461A 1980-10-14 1982-08-27 Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina AR229703A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19623180A 1980-10-14 1980-10-14
US06/293,574 US4374843A (en) 1980-10-14 1981-08-20 2-Guanidino-4-heteroarylthiazoles

Publications (1)

Publication Number Publication Date
AR229703A1 true AR229703A1 (es) 1983-10-31

Family

ID=26891753

Family Applications (3)

Application Number Title Priority Date Filing Date
AR290462A AR228674A1 (es) 1980-10-14 1982-08-27 Procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
AR290463A AR228675A1 (es) 1980-10-14 1982-08-27 Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
AR290461A AR229703A1 (es) 1980-10-14 1982-08-27 Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AR290462A AR228674A1 (es) 1980-10-14 1982-08-27 Procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
AR290463A AR228675A1 (es) 1980-10-14 1982-08-27 Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina

Country Status (28)

Country Link
US (1) US4374843A (el)
EP (1) EP0050458B1 (el)
KR (1) KR850001858B1 (el)
AR (3) AR228674A1 (el)
AT (1) ATE11048T1 (el)
AU (2) AU530589B2 (el)
CA (1) CA1156239A (el)
CS (1) CS231182B2 (el)
DD (4) DD202293A5 (el)
DE (1) DE3168067D1 (el)
DK (1) DK453181A (el)
ES (4) ES8301978A1 (el)
FI (1) FI75821C (el)
GR (1) GR75098B (el)
HK (1) HK52387A (el)
HU (2) HU191895B (el)
IE (1) IE51642B1 (el)
IL (1) IL64035A (el)
KE (1) KE3707A (el)
MY (1) MY8700512A (el)
NO (1) NO159654C (el)
NZ (1) NZ198629A (el)
PH (3) PH17562A (el)
PL (3) PL133712B1 (el)
PT (1) PT73817B (el)
SG (1) SG23487G (el)
SU (1) SU1153829A3 (el)
YU (4) YU42434B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
AU542287B2 (en) * 1982-06-17 1985-02-14 Toyama Chemical Co. Ltd. Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative, it:s salt and intermediates therefor
EP0156644A1 (en) * 1984-04-02 1985-10-02 Pfizer Inc. Process and intermediates for 4-acetylimidazoles
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (en) * 1986-08-29 1991-08-21 Pfizer Inc. 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
ATE106884T1 (de) * 1986-10-29 1994-06-15 Pfizer Verfahren zur herstellung von 2-(1-pentyl-3- guanidino)-4-(2-methyl-4-imidazolyl)thiazol und dessen kristallinisches dihydrochlorid-trihydrat.
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
WO1992016526A1 (en) * 1991-03-13 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
CN101287711A (zh) * 2005-08-23 2008-10-15 宇部兴产株式会社 1-取代-5-酰基咪唑化合物的制备方法
EP2832731A4 (en) 2012-03-27 2015-08-19 Shionogi & Co AROMATIC HETEROCYCLIC CHAIN 5-CORE DERIVED DERIVATIVE HAVING TRPV4 INHIBITORY ACTIVITY
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516777A (fr) * 1966-08-02 1968-02-05 Innothera Lab Sa Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
US3519637A (en) * 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
HU168776B (el) * 1973-11-09 1976-07-28
DE2614189A1 (de) * 1976-04-02 1977-10-20 Hoechst Ag Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives

Also Published As

Publication number Publication date
YU246481A (en) 1983-10-31
AU3206284A (en) 1984-11-29
PL133712B1 (en) 1985-06-29
FI813177L (fi) 1982-04-15
EP0050458B1 (en) 1985-01-02
AR228674A1 (es) 1983-03-30
CA1156239A (en) 1983-11-01
FI75821B (fi) 1988-04-29
IL64035A (en) 1986-01-31
AU530589B2 (en) 1983-07-21
EP0050458A3 (en) 1982-09-01
ES8306749A1 (es) 1983-06-01
CS750081A2 (en) 1984-02-13
IL64035A0 (en) 1982-01-31
SG23487G (en) 1987-07-10
PH17562A (en) 1984-10-01
CS231182B2 (en) 1984-10-15
PL241643A1 (en) 1983-11-21
YU42078B (en) 1988-04-30
HU186788B (en) 1985-09-30
HK52387A (en) 1987-07-17
AR228675A1 (es) 1983-03-30
FI75821C (fi) 1988-08-08
US4374843A (en) 1983-02-22
IE51642B1 (en) 1987-01-21
YU42076B (en) 1988-04-30
YU42077B (en) 1988-04-30
PL241644A1 (en) 1983-11-21
PL233430A1 (en) 1983-11-21
EP0050458A2 (en) 1982-04-28
DK453181A (da) 1982-04-15
DD207913A5 (de) 1984-03-21
KR830007638A (ko) 1983-11-04
HU191895B (en) 1987-04-28
PL135331B1 (en) 1985-10-31
ES8306751A1 (es) 1983-06-01
IE812384L (en) 1982-04-14
DE3168067D1 (en) 1985-02-14
DD207719A5 (de) 1984-03-14
KR850001858B1 (ko) 1985-12-28
ES515159A0 (es) 1983-06-01
YU105383A (en) 1983-10-31
NO159654C (no) 1989-01-25
DD202293A5 (de) 1983-09-07
ES506216A0 (es) 1982-12-16
YU105183A (en) 1983-10-31
YU105283A (en) 1983-10-31
MY8700512A (en) 1987-12-31
ES8306750A1 (es) 1983-06-01
ES515157A0 (es) 1983-06-01
NZ198629A (en) 1985-02-28
SU1153829A3 (ru) 1985-04-30
NO159654B (no) 1988-10-17
ES8301978A1 (es) 1982-12-16
PH18467A (en) 1985-07-18
PH17856A (en) 1985-01-09
GR75098B (el) 1984-07-13
YU42434B (en) 1988-08-31
ES515158A0 (es) 1983-06-01
DD207718A5 (de) 1984-03-14
PT73817A (en) 1981-11-01
KE3707A (en) 1987-04-03
ATE11048T1 (de) 1985-01-15
AU7628781A (en) 1982-04-22
NO813442L (no) 1982-04-15
AU548992B2 (en) 1986-01-09
PT73817B (en) 1983-11-07
PL134491B1 (en) 1985-08-31

Similar Documents

Publication Publication Date Title
AR229703A1 (es) Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
ES526899A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
MX154685A (es) Procedimiento para la preparacion de derivados de urea
ES534114A0 (es) Procedimiento para la preparacion de nuevas n-alcoxi y n-alquil-sulfonilaminosulfonilureas
MX163409B (es) Catalizadores de plata,procedimiento para su preparacion y su utilizacion para la preparacion de oxido de etileno
ES505423A0 (es) Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
ES549119A0 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
MX162490A (es) Catalizadores de plata,procedimiento para su preparacion y su utilizacion para la preparacion de oxido de etileno
ES503759A0 (es) Procedimiento para la preparacion de lapices cosmeticos
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
AR228678A1 (es) Procedimiento para la preparacion de 4-(2-imidazolil)piridinas 2-sustituidas utiles como agentes antiulcerantes
ES500455A0 (es) Procedimiento para la preparacion de nuevos derivados de urea
ES536795A0 (es) Procedimiento para la preparacion de nonapeptidos y dodecapeptidos
IT8049815A0 (it) Composti eterociclici attivi sui recettori istaminici e procedimento per la loro preparazione
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
AR228620A1 (es) Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
ES543832A0 (es) Procedimiento para la obtencion de fenilsulfonilureas susti-tuidas
IT8319192A0 (it) 1,3,4-tiadiazolo [3,2-a] pirimidine sostituite e procedimento per laloro preparazione
IT1164633B (it) 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES500114A0 (es) Procedimiento de preparacion de nuevas guanidinas aciladas, ureas y ureas sustituidas
AR229873A1 (es) Procedimiento para la preparacion de nuevos 3-2-hidroxi-fenil-4-sustituido-4 o 5-sustituido cicloalcanoles y derivados de los mismos,utiles como agentes analgesicos y como agentes antiemeticos y compuestos intermedios utilizados
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas